TG Therapeutics TGTX Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's interest coverage?
- TG Therapeutics (TGTX) reported interest coverage of 5.4× in Q1 2026.
- How has TG Therapeutics's interest coverage changed year-over-year?
- TG Therapeutics's interest coverage increased by 158.9% year-over-year, from 2.1× to 5.4×.
- What is the long-term trend for TG Therapeutics's interest coverage?
- Over 4 years (2020 to 2025), TG Therapeutics's interest coverage has grown at a -42.8% compound annual growth rate (CAGR), from -43.2× to 4.6×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.